Long‐Term Serial Exercise Stress Testing in Catecholaminergic Polymorphic Ventricular Tachycardia on Beta‐Blocker and Flecainide Therapy
Journal of Cardiovascular Electrophysiology · 30.06.2026
DOI: 10.1111/jce.70429 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cardiovascular Electrophysiology, online erschienen am 30.06.2026. Verfasst von Fernando Wangüemert-Perez und 9 weiteren Autor:innen. Beteiligte Einrichtung: Cardiavant, Centro Médico Cardiológico, Las Palmas de Gran Canaria, Spain. Hauptthemen laut MEDLINE: Flecainide, Tachycardia, Ventricular, Exercise Test, Adrenergic beta-Antagonists. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fundación Canaria UMIAYA for the care of sudden death.
Abstract (Originalsprache)
Introduction
Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a potentially life‐threatening arrhythmic disorder typically treated with beta‐blockers and, occasionally, with flecainide.
Methods
All patients underwent genetic testing, electrocardiogram, echocardiogram, and exercise testing. Ventricular arrhythmias were assessed using qualitative and quantitative scoring systems. Flecainide dosing was progressively titrated, and follow‐up extended from 2007 to 2024.
Results
Among 235 genetically confirmed carriers of the RyR2 (ryanodine receptor 2) p.Gly357Ser mutation, 32 required combination therapy with beta‐blockers and flecainide (age at diagnosis 18 [1–55] years; age at flecainide initiation 32 [15–66] years; 50% male). Forty‐seven percent had an implantable cardioverter defibrillator (ICD). Flecainide was indicated for exercise‐induced ventricular arrhythmias despite beta‐blocker therapy, and the median treatment duration was 7.3 years. All patients received propranolol (median dose 65 mg/day). Flecainide (median dose 100 mg/day) was well tolerated, with no syncope or stress‐induced symptoms. Before flecainide, five patients (16%) experienced ventricular arrhythmic events recorded by the ICD, including two requiring appropriate shocks; no events occurred after treatment initiation. Both qualitative (2.07 ± 0.77 vs. 1.22 ± 1.08, p < 0.001) and quantitative (69.78 ± 83.17 vs. 15.29 ± 5.53, p < 0.001) arrhythmic scores improved significantly. Additionally, maximum heart rate and the percentage of age‐predicted maximum heart rate were significantly reduced, while metabolic equivalents increased significantly (12.3 ± 3.8 vs. 14.7 ± 7.5; p = 0.010).
Conclusion
In CPVT patients, the addition of flecainide to beta‐blocker therapy was associated with a significant reduction in arrhythmic burden and improvement in exercise‐related parameters during long‐term follow‐up.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cardiavant, Centro Médico Cardiológico, Las Palmas de Gran Canaria, Spain.
- Cardiology Service, Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, Spain.
- Faculty of Health Sciences, Department of Medical and Surgical Sciences, Universidad de Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain.
- Cardiology Service, Complejo Hospitalario Universitario Insular-Materno Infantil, Las Palmas de Gran Canaria, Spain.
- Cardiovascular Genetics Center, Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta, Girona, Spain.
- Arrhythmia Section, Cardiology Department, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.
ORCID-Profile: Efrén Martínez-Quintana
Förderung
- Fundación Canaria UMIAYA for the care of sudden death
Zitieren
APA
Wangüemert-Perez, F., Ostos-Cañero, G., Wangüemert-Guerra, M., Acosta-Materan, C., Cárdenes-León, A., Caballero-Dorta, E., Pérez-Rodríguez, K., Brugada, R., Brugada, J., & Martínez-Quintana, E. (2026). Long‐Term Serial Exercise Stress Testing in Catecholaminergic Polymorphic Ventricular Tachycardia on Beta‐Blocker and Flecainide Therapy. Journal of Cardiovascular Electrophysiology. https://doi.org/10.1111/jce.70429
Vancouver
Wangüemert-Perez F, Ostos-Cañero G, Wangüemert-Guerra M, Acosta-Materan C, Cárdenes-León A, Caballero-Dorta E, et al. Long‐Term Serial Exercise Stress Testing in Catecholaminergic Polymorphic Ventricular Tachycardia on Beta‐Blocker and Flecainide Therapy. Journal of Cardiovascular Electrophysiology. 2026. doi:10.1111/jce.70429
BibTeX
@article{WangemertPerez2026,
author = {Wangüemert-Perez, Fernando and Ostos-Cañero, German and Wangüemert-Guerra, Marta and Acosta-Materan, Carlos and Cárdenes-León, Aridane and Caballero-Dorta, Eduardo and Pérez-Rodríguez, Kevin and Brugada, Ramón and Brugada, Josep and Martínez-Quintana, Efrén},
title = {Long‐Term Serial Exercise Stress Testing in Catecholaminergic Polymorphic Ventricular Tachycardia on Beta‐Blocker and Flecainide Therapy},
journal = {Journal of Cardiovascular Electrophysiology},
year = {2026},
doi = {10.1111/jce.70429}
}
EUVIMED